Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America.
Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI.
Kerur B, et al. Among authors: heyman mb.
J Pediatr Gastroenterol Nutr. 2022 Jul 1;75(1):64-69. doi: 10.1097/MPG.0000000000003464. Epub 2022 May 27.
J Pediatr Gastroenterol Nutr. 2022.
PMID: 35622080